Circumferential pulmonary vein antrum ablation for the treatment of paroxysmal atrial fibrillation: A randomized controlled trial.
Qiang XuWeizhu JuFangyi XiaoBing YangHongwu ChenGang YangFeng-Xiang ZhangKai GuMingfang LiDaowu WangMing-Long ChenPublished in: Pacing and clinical electrophysiology : PACE (2020)
The trial shows that sufficient force-sensing guided PVAM can result in satisfying outcomes in PAF patients. Notably, sufficient PVAM with all-PV isolated will further increase the success rate.
Keyphrases
- atrial fibrillation
- end stage renal disease
- catheter ablation
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- left atrial
- study protocol
- randomized controlled trial
- left atrial appendage
- percutaneous coronary intervention
- oral anticoagulants
- direct oral anticoagulants
- patient reported outcomes
- coronary artery disease
- insulin resistance
- phase ii
- combination therapy
- skeletal muscle
- left ventricular
- mitral valve